Ziprasidone in the Treatment of Borderline Personality Disorder

Clinical trial NCT00635921 · COMPLETED

Trial details

NCT number: NCT00635921
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2004-03-01
Primary completion: 2006-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.